When to Use Caution With Glutathione Supplementation Important Note: If you experience increased fatigue, nausea, joint or muscle aches, or any other adverse reaction when taking glutathione, seek the attention of a functional medicine-trained dietitian or physician
GLP-1 medicines and the treatment of obesity GLP-1RAs led to weight loss investigations, with liraglutide 3 mg daily approved for weight loss in 2014, followed by semaglutide 2.4 mg weekly in 2021, and tirzepatide in 2023
10.1186/s12864-020-06944-w Summary Keywords TMAO (trimethylamine oxide), MAFLD (metabolic associated fatty liver disease), trimethylamine, TMA precursor, FMO3, unfolded protein response, oxidative stress Citation Li X, Hong J, Wang Y, Pei M, Wang L and Gong Z (2021) Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD
Research into microneedle patch technology is underway to deliver real GLP-1 medications, but its still in the initial phases
When skin has been significantly stretched after obesity or massive weight loss, skin removal procedures may be the only way to fully address excess tissue